Real‐world safety and efficacy data of ipilimumab in Japanese radically unresectable malignant melanoma patients: A postmarketing surveillance-Reference-Cited by-同舟云学术

Real‐world safety and efficacy data of ipilimumab in Japanese radically unresectable malignant melanoma patients: A postmarketing surveillance

Author:

Yamazaki Naoya¹^ORCID,Kiyohara Yoshio²,Uhara Hisashi³,Tsuchida Tetsuya⁴,Maruyama Keiko⁵,Shakunaga Naoki⁵,Itakura Eijun⁵,Komoto Akira⁵

Affiliation:

1. Department of Dermatologic Oncology National Cancer Center Hospital Tokyo Japan

2. Dermatology Division Shizuoka Cancer Center Hospital Nagaizumi Japan

3. Department of Dermatology Sapporo Medical University Sapporo Japan

4. Department of Dermatology Saitama Medical University Moroyama Japan

5. Bristol‐Myers Squibb K.K. Tokyo Japan

Funder

Ono Pharmaceutical Co, Ltd.

Bristol-Myers Squibb

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

Reference27 articles.

4. Epidemiologic survey of malignant skin tumors – international comparison between Japan and foreign countries;Fujisawa Y;Nihon Rinsho,2013

5. Epidemiology of the melanoma;Fujisawa Y;Current Ther,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献